For secondary care use only.
Refer to NICE CG 172 MI-Secondary Prevention, for information on secondary prevention in primary and secondary care for patients following a myocardial infarction.
See also rivaroxaban▼ in Acute Coronary Syndrome.
Refer to NICE CG 172 MI-Secondary Prevention, for information on secondary prevention in primary and secondary care for patients following a myocardial infarction.
See also rivaroxaban▼ in Acute Coronary Syndrome.